For Immediate Release: April 10, 2023
Contact: Ryan Hite, Communications Director
Washington, D.C.: Federal Judge Matthew Kacsmaryk ruled on Friday to halt the FDA’s approval of “mifepristone,” one of two primary drugs used in chemical abortions. This judicial ruling has rapidly drawn responses and possible actions from both the executive and legislative branches.
“Judge Kacsmaryk spoke the unashamed truth in his 67-page ruling, and he’s raised all of the left’s hatred for it,” said Ed Martin, president of Phyllis Schlafly Eagles. “The media machine has gone into rapid response mode, furiously spitting out lie after lie about the medical cocktail that’s been halted, but the Judge is right to hit pause. Far from picking a side in the abortion fight, Judge Kacsmaryk stuck to the facts.”
“The truth is, the FDA has stonewalled challenges to ‘mifepristone’ (also known as RU_486) for more than two decades,” Martin continued. “In fact, the problems with mifepristone have been so great over the years that it must be prescribed with an accompanying drug to ‘finish the job’ of killing an unwanted child. This deadly medication for children in utero often leads to serious health complications for the mother as well. The judge is absolutely spot-on in halting the FDA’s accelerated approval of these drugs, as they have not proven their case that the drugs are ‘safe and effective.’
“Of course, this court decision is a threat to a very agenda-driven Biden executive branch. HHS Secretary Xavier Becerra has already implied that he’s open to simply defying the court’s order. His dismissive response was noticed and quickly addressed by members of the House Appropriations Committee who were quick to remind the public of their powers of oversight and the purse. If the FDA wants to ignore judicial order, the House could simply defund them!”
Martin concluded, “I think it’s high time we had a serious reminder of how checks and balances work. I look forward to Congress using its power of oversight and finance as this discussion over dangerous drugs and a politically driven FDA play out. We must have accountability now over the out-of-control executive branch and their bureaucrats who guide healthcare policy by politics.”